NCT07409740 is a clinical trial in Hydroxychloroquine Retinopathy, sponsored by Sohag University.

Who is sponsoring NCT07409740?

NCT07409740 is sponsored by Sohag University.

What condition does NCT07409740 study?

NCT07409740 studies Hydroxychloroquine Retinopathy.

Is NCT07409740 still recruiting?

NCT07409740 is currently not yet recruiting. Last updated 13 February 2026.

Last reviewed 2026-02-13 · How we verify

NCT07409740

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optical Coherence Tomography Angiography Evaluation Of Patients Taking Hydroxychloroquine

Not yet recruiting Last updated 13 February 2026

What this trial tests

trial in Hydroxychloroquine Retinopathy in 90 participants. Not yet recruiting.

Timeline

1 February 2026

Primary endpoint
1 August 2026

1 September 2026

Quick facts

Lead sponsor	Sohag University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	90
Start date	1 February 2026
Primary completion	1 August 2026
Estimated completion	1 September 2026

Conditions studied

Hydroxychloroquine Retinopathy — all drugs for Hydroxychloroquine Retinopathy →

Sponsor

Sohag University

Who can join

18 and older, any sex, with Hydroxychloroquine Retinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate retinal and choroidal microvascular changes using optical coherence tomography angiography (OCTA) in patients receiving hydroxychloroquine therapy. Hydroxychloroquine is commonly used in the treatment of autoimmune diseases and may cause retinal toxicity with long-term use. OCTA is a non-invasive imaging modality that allows detailed assessment of retinal vascular changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hydroxychloroquine Retinopathy

Currently open trials in the same condition.

NCT05355415 — Adaptive Optics Imaging of Outer Retinal Diseases · recruiting

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07409740 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 13 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07409740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing